Revenue: The sum of all revenue fields included for a company's operating activities.
Jazz Pharmaceuticals PLC (JAZZ) had Revenue of $1.01B for the most recently reported fiscal quarter, ending 2023-12-31.
| Income Statement Financials | |
|
Revenue |
$1.01B |
$119.03M |
|
$107.24M |
|
$904.69M |
|
$889.44M |
|
$122.50M |
|
$-60.97M |
|
$61.53M |
|
$61.53M |
|
$94.61M |
|
$94.15M |
|
$94.15M |
|
$94.61M |
|
$122.50M |
|
$281.70M |
|
63.29M |
|
72.07M |
|
$1.50 |
|
$1.40 |
|
| Balance Sheet Financials | |
$3.44B |
|
$169.65M |
|
$7.96B |
|
$11.39B |
|
$1.54B |
|
$5.11B |
|
$6.12B |
|
$7.66B |
|
$3.74B |
|
$-3.43B |
|
$3.74B |
|
62.26M |
|
| Cash Flow Statement Financials | |
$1.09B |
|
$-163.06M |
|
$-305.25M |
|
$881.48M |
|
$1.51B |
|
$624.83M |
|
$226.84M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.24 |
|
-- |
|
-- |
|
0.58 |
|
1.53 |
|
89.40% |
|
12.11% |
|
12.11% |
|
-- |
|
6.08% |
|
11.76% |
|
$1.07B |
|
-- |
|
-- |
|
-- |
|
0.09 |
|
0.18 |
|
1.43 |
|
62.77 |
|
2.52% |
|
-2.74% |
|
0.83% |
|
1.06% |
|
$60.03 |
|
$14.82 |
|
$15.15 |
|